Send feedback

TPP2 p.Val1070Ile

c.3208G>A · rs373674738 · VCV662616

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
AlphaMissense
likely benign
0.1067 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0331%, mid)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
AlphaMissense0.1067likely benign
REVEL0.122moderately benign-leaning
SaProtLLR -6.66tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2.4, phastCons 1
Regional constrainto/e 0.65unconstrained · MANE · 18 kb · p 7.8e-09 · regional, not allelic
Overall
CADD24.3PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM V1057I vs ClinVar V1070I) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0331% Middle Eastern · 2/6,038 alleles
Filtering AF 0.0187% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0158%
Overall 0.00586% 94/1,604,846 alleles · ultra-rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0849% 1,178
Middle Easterngrpmax 0.0331% 3,019
South Asian 0.0271% 3,693
Remaining individualsnot grpmax-eligible 0.0113% 8,881
East Asian 0.00451% 22,177
European (non-Finnish) 0.0028% 35,661
Admixed American 0.00171% 58,420

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
TPP2
Protein
p.Val1070Ile
Coding
c.3208G>A
MANE Select
NM_001330588
dbSNP
rs373674738
Type
single nucleotide variant
Location
chr13:102663712 (GRCh38)
Gene constraint
LOEUF 0.29 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 91.98
Residue 1070
a UniProt-annotated variant site (in imd78; loss of expression)
Full TPP2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tpp2-p-val1070ile (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown